Brain tumour clinical trial title
MISSION: GliomaS – A physiological exploratory study to assess tissue structure and metabolism in Glioma using sodium-23 Magnetic Resonance Imaging (23Na-MRI) (Study ID: 33936)
Brain tumour type
Glioma,
Website
www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/mission-gliomas/
Description:
Cancer cells undergo a change in structure and an increase in metabolism that can be imaged using Sodium-23 magnetic resonance imaging (23Na-MRI), Hyperpolarized Carbon-13 magnetic resonance spectroscopic imaging (13C-MRSI) and other novel techniques, such as Diffusion Kurtosis Imaging (DKI). These techniques will be investigated in this trial. The development, optimization and validation of these techniques may provide a deeper understanding of the physiology of cancer with a significant improvement in diagnosis and management of patients with gliomas.
Date added:
11th January 2019
Open/Closed:
Open
Trial ends:
March 2019
Provider
Cambridge University Hospitals NHS Trust
Contact details